Almujtama Alraida Medical Co.

Almujtama Alraida Medical Co.

TTADAWUL:9592
20.00
SAR
0.00
(0.00%)
211.85MMarket Cap
Almujtama Alraida Medical Co.
TADAWUL:9592
(Saudi Exchange)

Recent

price

20.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
TTM
SAR
32.05
38.64
42.92
45.34
47.87
- -
Revenue per Share
0.82
2.01
1.2
0.83
0.88
- -
Basic EPS, GAAP
1.05
-0.11
7.17
4.6
2.63
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
0.92
12.48
13.66
14.54
13.3
14.63
Book Value per Share
0.74
12.32
13.52
14.42
13.3
14.54
Tangible Book Value per Share
10
10
10
10
10
10
Basic Weighted Avg Shares
304
367
408
431
455
- -
Sales/Revenue/Turnover
3.49
6.57
3.42
1.8
2.36
- -
Operating Margin (%)
24
22
- -
- -
- -
- -
Depreciation Expense
8
19
11
8
8
- -
Net Income, GAAP
6.1
9.91
- -
- -
- -
- -
Effective Tax Rate (%)
2.56
5.2
2.79
1.84
1.85
- -
Profit Margin (%)
-39
52
20
13
15
10
Working Capital
97
103
141
140
- -
127
LT Debt
9
119
130
138
126
139
Total Equity
- -
11.7
5.42
2.82
5.3
- -
Return on Invested Capital (%)
- -
12.52
6.81
5.8
8.73
- -
Return on Capital (%)
- -
29.97
9.17
5.92
6.35
- -
Return on Common Equity (%)

Capital Structure

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
38
- -
74
LT Borrowings
- -
- -
- -
LT Finance Leases
145
- -
127
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
295
282
212

Working Capital

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
229
242
214
Cash, Cash Equivalents & STI
7
7
8
Accounts Receivable, Net
40
- -
11
Inventories
173
- -
185
Total Current Liabilities
213
227
205
Payables & Accruals
- -
- -
- -
ST Debt
38
- -
74
Deferred Revenue
- -
- -
- -

Growth Rates

SAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-8.56%
Free Cash Flow
- -
- -
-42.76%
Net Income, GAAP
- -
- -
5.86%
Sales/Revenue/Turnover
- -
- -
5.57%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
431
2025
- -
- -
455
2026
- -
- -
- -

Semi-annual Earnings Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.83
2025
- -
- -
0.88
2026
- -
- -
- -

Semi-annual Dividends Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
Almujtama Alraida Medical Co. (9592.SR) operates a chain of pharmacies and provides pharmaceutical services across Saudi Arabia. The company retails prescribed medicines, over-the-counter pharmaceutical products, cosmetics, toiletries, medical equipment, instruments, and supplies; it also publishes a magazine focused on medical and pharmaceutical health topics and offers products through an online platform. Founded in 2001 and headquartered in Jeddah's Al-Hamdaniya District, the firm serves retail consumers and operates primarily in the Western Region of Saudi Arabia with approximately 157 pharmacies, including branches in Ministry of Health outpatient clinics, supported by a central warehouse in Jeddah's Third Industrial City. In recent developments, the company completed automation of its warehouse in October 2025 to enhance operational efficiency; signed a non-binding memorandum of understanding in October 2025 with Badayat Al-Amal for Trading to expand e-commerce, supply chains, pharmaceutical imports, cosmetics, and medical devices over 18 months; entered an exclusive commercial distribution agreement with Turkish firm GSS Marketing; and established a partnership with Mohammad Abdullah Abunayyan Investment Co. (formerly Meem Alif Co.) to form an import company. These initiatives reflect strategic expansions in digital services, imports, and distribution amid the healthcare and consumer retailing sectors.